Your browser doesn't support javascript.
loading
Discovery and repurposing of artemisinin.
Shi, Qiaoli; Xia, Fei; Wang, Qixin; Liao, Fulong; Guo, Qiuyan; Xu, Chengchao; Wang, Jigang.
Afiliación
  • Shi Q; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
  • Xia F; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
  • Wang Q; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
  • Liao F; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
  • Guo Q; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. qyguo@icmm.ac.cn.
  • Xu C; Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. ccxu@icmm.ac.cn.
  • Wang J; Department of Geriatrics, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People's Hospital, Shenzhen, 518020, China. ccxu@icmm.ac.cn.
Front Med ; 16(1): 1-9, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35290595

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Asunto principal: Artemisininas / Tratamiento Farmacológico de COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Med Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Asunto principal: Artemisininas / Tratamiento Farmacológico de COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Med Año: 2022 Tipo del documento: Article País de afiliación: China